Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxyapatite is a naturally occurring mineral form of calcium apatite, comprising the main inorganic structural component of human enamel and bone. Enamel hydroxyapatite regeneration refers not to a specific biological target such as an enzyme or receptor, but to the use or induction of hydroxyapatite mineral formation for the repair and remineralization of tooth enamel lost to caries, acid wear, or developmental defects. In dental care, synthetic or biomimetic hydroxyapatite is used to restore enamel function, providing a structural barrier, facilitating remineralization, and protecting against further demineralization. The process involves direct deposition and crystal growth on the tooth surface, sometimes enhanced with biomimetic strategies such as polymer templates (e.g., PAMAM dendrimers). Hydroxyapatite is distinct from canonical drug targets, as it is a physical mineral and not a molecular receptor, enzyme, or transporter[1][2][3][4][5][7]. **Note:** Hydroxyapatite is *not* a therapeutic target in the conventional sense. It is a mineral substrate used as a treatment material. The phrase “enamel hydroxyapatite regeneration” does not refer to a molecular target but rather a therapeutic process or mechanism. Therefore, this entry is marked as “is_incorrect: true” for being a process not a druggable biological target.
Surface mineral deposition (formation of protective hydroxyapatite layer on enamel) ; Calcium and phosphate ion release supporting remineralization ; pH buffering via neutralization of bacterial acids ; Physical blocking of open dentinal tubules (sensitivity relief) ; Scaffold for biomimetic enamel growth
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyapatite (enamel regeneration context) (HAP).